Clinical Trial Update: Study of Evaluating Safety and Immunogenicity of 10µg/0.5ml Hepatitis B Vaccine [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and immunogenicity of a 10 µg/0.5 mL Hepatitis B vaccine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepatitis B vaccine (10 µg/0.5 mL) (Hepatitis B vaccine)

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED